ROVI.MC - Laboratorios Farmaceuticos ROVI, S.A.

MCE - MCE Delayed Price. Currency in EUR
16.00
-0.05 (-0.31%)
At close: 4:09PM CET
Stock chart is not supported by your current browser
Previous Close16.05
Open16.00
Bid0.00 x 8400
Ask0.00 x 15000
Day's Range15.90 - 16.00
52 Week Range12.65 - 18.75
Volume40,437
Avg. Volume10,056
Market Cap789.069M
BetaN/A
PE Ratio (TTM)36.53
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Laboratorios Farmaceúticos Rovi SA : Overvalued relative to peers, but may deserve another look
    Capital Cube9 months ago

    Laboratorios Farmaceúticos Rovi SA : Overvalued relative to peers, but may deserve another look

    Categories: Yahoo FinanceLaboratorios Farmaceúticos Rovi SA relative valuation is now OVERVALUED. It was previously rated UNDERVALUED, and has a fundamental analysis score of 78. Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT). Relative ... Read more (Read more...)

  • Laboratorios Farmaceúticos Rovi SA : A good buy now? Relative to peers, maybe.
    Capital Cube11 months ago

    Laboratorios Farmaceúticos Rovi SA : A good buy now? Relative to peers, maybe.

    Categories: Yahoo Finance Laboratorios Farmaceúticos Rovi SA relative valuation is now UNDERVALUED. It was previously rated OVERVALUED, and has a fundamental analysis score of 72. Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT). Relative ... Read more (Read more...)

  • We're sorry this is all we were able to find about this topic.